Innogen  ·  Publications  ·  Journal articles
Industry challenges: Joyce Tait and James Mittra discuss complexity and innovation in the pharma industry

Tait, J   Mittra, J

Chemistry and Industry (Society of Chemical Industry)   23 24

December 2004

http://www.highbeam.com/doc/1G1-126198445.html

Companies in the pharmaceuticals sector are facing increasingly turbulent conditions in their relations with other companies, policy makers, regulators and members of the public. On top of the usual uncertainty about which research areas are going to lead to the next big breakthrough - what will work and what will not - there are many new issues that could affect the industry's future. These include how to bring radically new types of product, such as biotech and genomics drugs, or stem cells, to the market; a changing regulatory environment; the impact of health service purchasing policies and other market-related factors, and public/stakeholder acceptance of new drugs and medical procedures.